Yes, Taper Bupropion XL 150mg After 5 Years of Use
For a patient on bupropion XL 150mg daily for 5 years, tapering is advisable to minimize withdrawal symptoms, even though this is the lowest available dose of the extended-release formulation. The FDA label explicitly recommends tapering when discontinuing bupropion XL 300mg (reducing to 150mg before stopping), and this principle should extend to patients already on 150mg 1.
Why Tapering Matters
While bupropion is not classified as having the same discontinuation syndrome severity as SSRIs or SNRIs, withdrawal symptoms can still occur. The guideline evidence for antidepressants consistently emphasizes that dose tapering is advisable to reduce the risk of discontinuation syndrome 2. After 5 years of continuous use, the patient's neurochemical systems have adapted to chronic dopamine/norepinephrine reuptake inhibition, making abrupt cessation potentially problematic.
Practical Tapering Approach
Since 150mg XL is the lowest commercially available dose, you have several options:
Option 1: Switch to Immediate-Release Formulation
- Switch to bupropion IR 100mg twice daily (equivalent to 150mg XL)
- After 1-2 weeks, reduce to 100mg once daily
- After another 1-2 weeks, reduce to 75mg once daily (half a 150mg IR tablet)
- Continue for 1-2 weeks, then discontinue
Option 2: Extended Interval Dosing
- Continue 150mg XL but increase dosing interval to every other day for 2 weeks
- Then every third day for 1-2 weeks
- Then discontinue
Option 3: Tablet Splitting (Less Ideal)
- While the FDA label states XL tablets should not be crushed or divided 1, some clinicians use careful splitting as a last resort
- This compromises the extended-release mechanism but may be preferable to abrupt discontinuation
Timeline Recommendation
A 4-6 week taper is reasonable for most patients on 150mg for 5 years. This is more conservative than the brief tapers mentioned in smoking cessation guidelines 3, 4 but appropriate given the duration of use and the fact that this patient is likely taking bupropion for depression rather than smoking cessation.
Monitoring During Taper
Watch for withdrawal symptoms including:
- Mood changes: irritability, anxiety, depressed mood
- Physical symptoms: headache, dizziness, fatigue
- Sleep disturbances: insomnia or vivid dreams
- Cognitive effects: difficulty concentrating
If withdrawal symptoms emerge, pause the taper at the current dose for 1-2 weeks before attempting further reduction 2. The patient can always slow down or temporarily reverse the taper if symptoms become problematic.
Important Caveats
Do not confuse withdrawal symptoms with depression relapse. Withdrawal typically emerges within days of dose reduction and improves over 1-2 weeks, while relapse develops more gradually over weeks to months. If uncertain, holding at the current dose (rather than increasing back to the original dose) can help differentiate 5, 6.
The risk of seizures does not increase during tapering—in fact, discontinuing bupropion eliminates the seizure risk associated with the medication 3, 4.